GW Pharma (GWPH) PT Lowered to $160 at Leerink Partners
Tweet Send to a Friend
Leerink Partners lowered its price target on GW Pharma (NASDAQ: GWPH) to $160.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
